Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “P2Y12 Inhibitor”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07164859
What this trial is testing

Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

Who this might be right for
Coronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)Antiplatelet Therapy+1 more
Vincent ROULE 1,700
Post-approval studies (Phase 4)Looking for participantsNCT05681702
What this trial is testing

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

Who this might be right for
Coronary Artery Disease
University of Florida 90
Not applicableNot Yet RecruitingNCT05650411
What this trial is testing

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

Who this might be right for
Left Main Coronary Artery Stenosis
IGLESIAS Juan Fernando 828
Not applicableLooking for participantsNCT05785897
What this trial is testing

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

Who this might be right for
ST Elevation Myocardial Infarction
IGLESIAS Juan Fernando 350
Post-approval studies (Phase 4)Looking for participantsNCT04014803
What this trial is testing

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Who this might be right for
Coronary Artery Disease
Samsung Medical Center 3,500
Post-approval studies (Phase 4)Looking for participantsNCT06283888
What this trial is testing

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

Who this might be right for
ACS - Acute Coronary SyndromeCYP2C19 Polymorphism
Zunyi Medical College 1,200
Post-approval studies (Phase 4)Study completedNCT04006288
What this trial is testing

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University of Florida 90
Post-approval studies (Phase 4)Study completedNCT01950416
What this trial is testing

Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis

Who this might be right for
ST Elevation Myocardial InfarctionFibrinolysisP2Y12 Inhibitor
University of Patras 56
Post-approval studies (Phase 4)Not Yet RecruitingNCT06763744
What this trial is testing

Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

Who this might be right for
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)High Bleeding Risk
Samsung Medical Center 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00546260
What this trial is testing

Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI

Who this might be right for
Myocardial Infarction
Portola Pharmaceuticals 70
Post-approval studies (Phase 4)Ended earlyNCT03119012
What this trial is testing

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold

Who this might be right for
Coronary Artery DiseaseStentsAtherosclerosis
Samsung Medical Center 25
Not applicableStudy completedNCT01018940
What this trial is testing

Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease

Who this might be right for
Coronary Artery DiseasePeripheral Artery Disease
University of Oklahoma 30
Post-approval studies (Phase 4)Temporarily pausedNCT03729401
What this trial is testing

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND

Who this might be right for
Coronary Artery DiseaseMyocardial Infarction
Ottawa Heart Institute Research Corporation 390
Not applicableStudy completedNCT04492423
What this trial is testing

VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study

Who this might be right for
Coronary DiseasePlatelet Aggregation
Accriva Diagnostics 100
Early research (Phase 1)Study completedNCT03126695
What this trial is testing

Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Who this might be right for
Sickle Cell Disease
AstraZeneca 44
Not applicableLooking for participantsNCT06535568
What this trial is testing

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Who this might be right for
Coronary DiseaseHeart DiseasesCardiovascular Diseases+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Not applicableUnknownNCT03615846
What this trial is testing

Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan

Who this might be right for
Platelet AggregationCoronary Artery Disease
Accriva Diagnostics 147
Post-approval studies (Phase 4)Looking for participantsNCT06588595
What this trial is testing

The Switching Antiplatelet-9 (SWAP-9) Study

Who this might be right for
Coronary Arterial Disease (CAD)
University of Florida 90
Not applicableStudy completedNCT05581238
What this trial is testing

Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.

Who this might be right for
Platelet AggregationBlood Transfusion
Medisch Spectrum Twente 6,428
Testing effectiveness (Phase 2)Study completedNCT00751231
What this trial is testing

Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI

Who this might be right for
Percutaneous Coronary Intervention
Portola Pharmaceuticals 652
Load More Results